Introduction
The Met tyrosine kinase is a high-affinity receptor for hepatocyte growth factor (HGF) (1, 2) . Both Met and HGF are expressed in various tissues, and signaling via this receptor-ligand pair has been shown to affect a variety of biological activities, including cell growth (3, 4) , cellular motility (5) and angiogenesis (6) . Aberrant activation of HGF/Met signaling via paracrine or autocrine activation has been implicated in the generation and spread of many types of human cancers, including major carcinomas as well as sarcomas (7) . Notably, activating missense mutants of Met are found in human hereditary papillary renal carcinomas (8) and these mutants have been shown to possess constitutive kinase activity and transforming ability (9) . Activating mutations of Met are also found in ovarian cancer (10) , early-onset hepatocellular carcinoma (11) and gastric carcinoma (12) , indicating that the activation mutation of Met is a general mechanism causing various human cancers.
Growth factors/growth factor receptors play a critical role in initiating signaling cascades that stimulate cell cycle progression at G 1 /S phase. Oncogenic receptor tyrosine kinases (RTKs) derived from mutant growth factor receptors allow cells to pass over the G 1 /S checkpoint, triggering uncontrolled cell proliferation. The Rasextracellular signal-regulated kinase (ERK) and phosphoinositide 3-kinase (PI3K)-Akt are major signaling activators that are responsible for uncontrolled cell proliferation as well as for anti-apoptotic signals (13, 14) . So far, the ability of oncogenic RTKs to transform cells has been thought to mainly rely on their mitogenic and anti-apoptotic effects (15) . Recently, however, evidence is accumulating that genomic instability is a crucial factor in tumorigenesis (16, 17) . Interestingly, some of the key signaling molecules related to growth factors have been reported to induce genomic instability. The activated Ras increased genomic instability of thyroid cells in which the Ras-mediated cell transformation seemed to occur after acquisition of the impaired DNA damage response (18) . In addition, aberrant Wnt/b-catenin signaling, an important driving force of tumorigenesis in many cancers, accompanied with chromosomal instability (CIN) in cells (19) , suggesting that growth signaling molecules not only control cell cycle progression at G 1 /S phase but may also extend to mitotic regulation.
CIN is characterized by losses or gains of chromosome number and changes in chromosome structure (20) and can be caused by an increased rate of chromosomal missegregation during mitosis (21) . Abnormal number of centrosome, a microtubule-organizing center, is often associated with the multipolar mitotic spindles that consequently cause chromosomal missegregation (22, 23) . Centrosome amplification is considered as a major contributing factor for CIN in cancer development because a significant fraction of human cancers commonly show centrosome defects (20, 22, 24, 25) . Cellular kinases of the cyclin-dependent kinase 2 (Cdk2)/cyclin E, Aurora, Polo and Nek families participate in the centrosome duplication cycle (26) and amplification or mutations of those kinases increase the frequency of centrosome abnormality (27) . So far, whether oncogenic signaling derived from aberrant growth factor/growth factor receptors are linked to the centrosome abnormality remains largely unknown.
In the present study, we first demonstrated that expression of oncogenic Met receptor in cells led to supernumerary centrosomes and aneuploidy. We showed that inhibition of Akt activity in these cells by using Akt small interfering RNAs (siRNAs) or overexpression of dominant-negative form of Akt (DN-Akt) abrogated supernumerary centrosome formation. Thus, oncogenic growth factor/growth factor receptor signaling may have cross talk to centrosome abnormality and genomic instability during tumorigenesis.
Materials and methods
Antibodies, plasmids and chemicals Fetal bovine serum, trypsin-ethylenediaminetetraacetic acid, antibioticantimycotic containing penicillin G sodium, streptomycin sulfate and amphotericin B were obtained from Gibco BRL (Carlsbad, CA). Protease inhibitor cocktail was purchased from Roche Applied Science (Mannheim, Germany). Phosphatase inhibitors, nocodazole, U0126 and LY294002 were from Sigma Chemical Co. (St Louis, MO). Rabbit polyclonal antibodies against the following antigens were purchased from Cell Signaling Technology (Beverly, MA): phopho-p44/42 mitogen-activated protein kinase (MAPK), p44/42 MAPK, phospho-p38 MAPK, p38 MAPK, phospho-stress-activated protein kinase/c-jun N-terminal kinase (JNK), stress-activated protein kinase/JNK, phospho-Akt and Akt. Mouse monoclonal c-tubulin antibody was purchased from Sigma Chemical Co.. Antibody against the N-terminal half of Cep-170 was generously provided by Dr G. Guarguaglini (28) , which confers resistance to G418, and a plasmid encoding the pMB1-CA-Met Met. MOCK cells were transfected with plasmid pSVneo and pMB1 empty vector. Cells were selected for 2 weeks with 800 lg/ml G418 (Life Technologies, Carlsbad, CA) and then grown as pools with 500 lg/ml G418.
Cell synchronization
For mitosis arrest, cells were treated with 100 ng/ml nocodazole for 12 h. To arrest the cells at G 1 -S boundary, double thymidine block was performed. Cells were treated with 1 lM thymidine for the first synchronization. Twenty hours later, cells were washed with thymidine-free medium (first release) and cultured in complete medium for 8 h. Then, cells were cultured again in thymidine-containing medium for 14 h for the second round of synchronization. After then, cells were washed with thymidine-free medium and cultured in complete medium (second or final release).
Cell cycle analysis by flow cytometry Cells synchronized at G 1 -S boundary by double thymidine block were trypsinized, centrifuged and fixed with 70% cold ethanol for 30 min. After samples were washed with phosphate-buffered saline (PBS) and then resuspended in a solution containing RNase A for 5 min, propidium iodide was added. After 5 min of incubation, samples were subjected to FACS analysis using a FACS Vantage flow cytometer (Becton Dickinson, Franklin Lakes, NJ).
Giemsa staining MOCK and CA-Met cells were exposed to 100 ng/ml nocodazole for 12 h, and mitotic cells were then collected, incubated at 37°C for 15 min in 0.075 M hypotonic KCl, pelleted and fixed with methanol:acetic acid (3:1) solution. After washing three times with PBS, samples were spreaded on slide glass, dried at room temperature (RT) and then stained with 3% (wt/vol) Giemsa staining solution.
Immunoblotting
Conventional immunoblotting was performed as previously described (29) using corresponding antibodies. Briefly, cell lysates (50 lg) were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then were transferred to nitrocellulose membrane. After blocking for 1 h at RT with PBS containing 0.05% (vol/vol) Tween-20 and 5% (wt/vol) nonfat milk, membranes were incubated with primary antibodies at 4°C, followed by washing with PBS containing 0.05% Tween-20 and incubated with horseradish peroxidase-conjugated anti-rabbit or anti-mouse antibody (Amersham Biosciences, Piscataway, NJ) for 1 h at RT. Detection was carried out using ECL reagents (Amersham Biosciences) and exposing them to x-ray film.
Immunofluoresence analysis Cells were fixed in methanol:acetone (1:1) solution and permeabilized with 0.075% Triton X-100. Fixed cells were pre-incubated in blocking solution (1% bovine serum albumin in PBS), followed by incubation overnight with primary antibodies at 4°C. Cells were then washed three times with shaking and probed with a rhodamine-conjugated anti-rabbit antibody (1:1000; Jackson ImmunoResearch Laboratories, West Grove, PA) or fluorescein isothiocyanateconjugated anti-mouse antibody for 1 h at RT. After washing, cells were mounted in the mounting solution containing 4#,6-diamidino-2-phenylindole and examined by confocal microscope (LSM510; Carl Zeiss, Oberkochen, Germany).
Knockdown experiment
Pre-designed siRNA oligonucleotides targeting for Akt (Akt1 and Akt2) were purchased from Life Technologies. HeLa cells (1 Â 10 4 ) were seeded in 35 mm dishes. After 24 h, cells were transfected with 200 nmol each of specific or non-silencing control siRNA oligonucleotides using Oligofectamine according to manufacturer's instruction (Life Technologies).
Results
Constitutive activation of Met signaling induced supernumerary centrosomes and multipolar spindle formation In order to address whether oncogenic Met tyrosine kinase receptor is linked to centrosome abnormality, we utilized the M1268T mutant, a strong constitutively activating form of Met that was originally found in human papillary renal cancer (8) . Stable cell lines were established by transfecting pMB1-M1268T complementary DNA into HeLa cells, followed by selection with G418. Among .50 clones, different clones (#1, #3 and #5) expressing M1268T were selected and analyzed for the Met activation. To determine the status of tyrosine phosphorylation of Met in these clones, cell lysates were subjected to immunoprecipitation using anti-murine Met antibody, followed by western blot analysis with anti-phosphotyrosine antibody. All these clones exhibited significant increases in the levels of tyrosine phosphorylation of Met ( Figure 1A ), verifying constitutively active states of Met (CAMet). Under microscope, all these clones also showed similar scattered growth pattern (data not shown), which is an indicator of cells with Met activation (30, 31) .
We then determined the number of centrosomes in asynchronously growing cells by staining for c-tubulin and counting .200 cells in each experiment. We found that $2% of control cells transfected with the pMB1 vector contained supernumerary centrosomes (n ! 3). In contrast, 6-9% of cells expressing CA-Met showed supernumerary centrosomes ( Figure 1B ), which was 3-to 4-fold higher than that of control cells (P , 0.005). Since different CA-Met clones did not yield differences in the activation of Met and in the formation of supernumerary centrosomes, we rationalized that these CA-Met clones can be pooled for further analysis.
At mitotic phase, centrosome duplication and segregation are completed and therefore, it is better to determine supernumerary centrosomes in mitotic cells. To count the number of centrosomes in mitotic phase, cells were arrested at prometaphase by nocodazole treatment and then released from the drug. At 60 min after release when most of cells remained at mitosis, numbers of centrosomes in each cell were determined by staining for c-tubulin ( Figure 1C , upper panel). Whereas $5% of the control cells contained .2 centrosomes (supernumerary centrosomes), $25% of cells expressing CA-Met contained supernumerary centrosomes, which was significantly higher than that of control cells ( Figure 1C , lower panel). In addition, tripolar and tetrapolar mitotic spindles with multidirectional chromosomal staining were significantly increased in CA-Met cells (15.8 ± 2.7% versus 2.4 ± 0.5%, P , 0.005) as shown in Figure 1D . Furthermore, chromosome segregation defects such as bridge chromosomes in anaphase cells were often observed ( Figure 1E , upper panel), and the frequency was significantly higher than that of control cells (P , 0.005) ( Figure 1E , lower panel).
Supernumerary centrosomes can be generated either by multiple cycles of centrosome duplication in a single cell cycle or by cytokinesis failure itself without overduplication of centrosomes (20) . Cells with supernumerary centosomes often fail to undergo cytokinesis due to formation of aberrant spindles. In turn, the cytokinesis block plays a secondary role in generation of supernumerary centrosomes. To investigate the possibility of centrosome duplication, we analyzed Cep170 protein, which localizes to only one mature centriole from G 1 to early G 2 phases, whereas two Cep170-positive centrioles can be shown through late G 2 to mitotic phase as two separated centrosomes (32) . In cells showing four centrosomes due to S phase arrest by hydroxyurea treatment, most contained one to three Cep170-positive staining and no cells showed four Cep170-positive staining (supplementary Figure 1 is available at Carcinogenesis Online). In contrast, cytokinesis failure by itself induced by cytochalasin D treatment greatly increased cells with four Cep170-positive staining up to .70%. Meanwhile, $80% of CA-Met cells contained one to three Cep170-positive staining, whereas ,20% of them displayed four Cep170-positive staining (supplementary Figure 1 is available at Carcinogenesis Online). These results indicate that supernumerary centrosomes in CA-Met cells are mainly driven by overduplication of centrosomes during cell cycle and partly by division failure. Together, this is the first indication that constitutive active Met signaling induces supernumerary centrosomes probably via deregulation of centrosome duplication cycle, which is probably to contribute to multipolar spindle formation and chromosomal bridge formation. 
CA-Met enhanced CIN
It has been shown that cells with severe aberrant chromosomes do not survive through cell cycle progression, whereas cells with relatively mild alterations in chromosome survive, increasing the chance for accumulation of CIN (33) . To address whether the cells with supernumerary centrosomes and multipolar spindle survived and revealed accumulation of CIN in interphase cells, we measured the frequency of multinuclei (Figure 2A Increasing extent of aneuploidy is one of the most representative indicator of CIN (34) . Using metaphase spread, we first determined numbers of chromosomes from vector control cells (n 5 300) and then divided them into three categories-N1, N2 and N3 ( Figure 2C ). The average number of chromosomes per one cell was determined as 59.2 in parental HeLa cells. To quantitatively express the extent of newly generated aneuploidy, we formulated, so called, an 'aneuploidy index'. The 'N2' window was defined as the window around the peak that 95% of cell population from parental HeLa cells belonged to and the aneuploidy index was defined as [(N1 þ N3)/(N1 þ N2 þ N3)] Â 100 (%). Thus, the aneuploidy index from parental HeLa cells should be 5% and the same window .7) . Notably, the aneuploidy index of CAMet cells was determined as 19.7% that was significantly higher than that of vector control cells (7.44%). Collectively, CAMet enhanced the extent of CIN probably through the formation of supernumerary centrosomes.
Activation of the PI3K-Akt pathway was necessary for centrosome amplification Cdk2/cyclin E kinase is a major player initiating centrosome duplication at G 1 /S phase and constitutive activation of Cdk2/cyclin E often leads to centrosome amplification (35, 36) . We first determined whether Cdk2/cyclin E kinase activity remained elevated in CA-Met cells using in vitro kinase assay using S phase cell lysates by releasing cells from the second thymidine block. We found that Cdk2/cyclin E kinase activity was not different between control and CA-Met cells (supplementary Figure 3 is available at Carcinogenesis Online), indicating that Cdk2/cyclin E was not a causative factor for centrosome amplification in CA-Met cells. We next assumed that cellular signaling kinases downstream of CA-Met might be involved in centrosome amplification. As shown in Figure 3A , western blot analysis revealed increased levels of phospho-ERK and phospho-Akt but not of phospho-p38 or phospho-JNK in CA-Met cells. Densitometry quantification revealed $8-fold increase of phospho-ERK and 2-fold increase of phospho-Akt ( Figure 3A , right panel) compared with control cells. To address which signaling pathway is responsible, we next applied chemical inhibitors against the ERK or PI3K to CA-Met cells to investigate their effects on the centrosome amplification. Synchronized cells were treated with each signaling inhibitor (U0126 for MEK1 and LY294002 for PI3K) and subjected to centrosome analysis. We analyzed only the cells in the mitotic phase (mainly metaphase) because these inhibitors may also interfere with cell cycle progression (37) . Interestingly, pretreatment with LY294002, but not U0126, significantly reduced the number of CA-Met cells with multiple centrosomes (!3) ( Figure 3B , P , 0.05). Moreover, inhibition of the PI3K pathway by LY294002 abrogated multinucleated cell formation in CA-Met cells ( Figure 3C , P , 0.005). At the concentration used for the experiment, both signaling pathways were effectively blocked as shown in Figure 3D .
To verify the importance of Akt in centrosome amplification of CAMet cells, we suppressed Akt activity by knockdown using siRNA or by overexpressing the DN-Akt or phosphatase and tensin homolog (PTEN), the phosphatase for PI3K products. Two different siRNAs specifically targeting Akt messenger RNA (Life Technologies) was applied to CA-Met cells 48 h before nocodazole treatment and resulted in a clear abrogation of centrosome amplification ( Figure 4A , P , 0.05) as well as multinucleated cell formation ( Figure 4B , P , 0.05). Consistently, transfection of DN-Akt or PTEN into CAMet cells also significantly suppressed centrosome amplification as well as multinucleated cell formation ( Figure 4C and D) , verifying the crucial role for the PI3K-Akt in centrosome amplification of CA-Met cells. Western blot analysis showed that 40-60% of Akt protein levels were diminished by Akt siRNA ( Figure 4E ) and cell cycle profiles were not changed by overexpression of PTEN ( Figure 4F ). Together, our data for the first time provide the evidence that the PI3K-Akt pathway is involved in deregulation of centrosome duplication in CAMet cells.
Increase of aneuploidy by CA-Met was observed in p53 À/À cells, but not in p53 þ/þ cells Loss of p53 tumor suppressor function in cells leads to severe impacts on centrosome duplication cycle (38) as well as maintenance of genomic integrity (39) . The p53 level in HeLa cells is very low, if any, because E6 and E6AP actively ubiquitinates and induces Fig. 3 . Abrogation of the increase of cells with multicentrosomes and multinuclei by treatment with LY294002, but not with U0126. (A) Cell lysates from vector and CA-Met transfectants were (50 lg protein) subjected to western blot analysis using anti-phospho-ERK1/2, phospho-JNK, phospho-Akt and phosphop38 antibodies. Representative data from three independent experiments are presented. At the right panel, the band intensities were determined by densitometry and the phosphorylation status was shown as fold changes to control. (B) CA-Met transfectants were treated with U0126 (10 lM) or LY294002 (30 lM) for 12 h and further incubated in the presence of 100 ng/ml nocodazole for 12 h. After removal of nocodazole, cells were reseeded onto cover glasses and allowed to progress for 60 min. The centrosomes were visualized by staining with anti-c-tubulin antibody. Cell number 5 300, mean ± SD from three independent experiments. Ã P , 0.05 by Student's t-test. (C) Vector and CA-Met transfectants were treated with U0126 (10 lM) or LY294002 (30 lM) for 12 h and then cells were subjected to 4#,6-diamidino-2-phenylindole staining for nucleus and immunostaining for a-tubulin. Cell number 5 300, mean ± SD from three independent experiments. ÃÃ P , 0.005 by Student's t-test. (D) Cell lysates from indicated samples (each containing 50 lg protein) were subjected to western blot analysis using anti-phospho-Akt, phospho-ERK1/2, anti-Akt and anti-ERK1/2 antibodies.
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degradation of the p53 protein (40) . In order to clarify the role for p53 in CA-Met-mediated CIN, we employed HCT116 human colon cancer cells with the background of p53 þ/þ or p53 À/À status. HCT116 p53 þ/þ and HCT116 p53 À/À cells were transfected with CA-Met expression vector and treated with G418 (500 lg/ml). The resultant stable clones ($100) were pooled and further cultivated for 2 months. First, we compared the number of centrosomes in these cells. Notably, overexpression of CA-Met in HCT116 p53 þ/þ cells did not increase supernumerary centrosomes ( Figure 5A ). In contrast, cells with supernumerary centrosomes were already abundant in HCT116 p53 À/À cells, reaching to $30% and overexpression of CA-Met did not cause a significant increase in these cells ( Figure 5A ). Next, we examined for progression of karyotypic profiles upon cell passages. The cells at the time of antibiotics selection were indicated as 0 month and further collected after 1 and 2 months through continuous passages. The passage numbers of each cell were essentially the same. In each analysis, three hundred metaphase cells were analyzed for karyotypic profiles. Notably, we observed that expression of CA-Met did not increase aneuploidy in HCT116 p53 þ/þ cells ( Figure 5B ) that is different from what we have observed in HeLa cells (Figure 2B ), suggesting that lack of p53 activity in HeLa cells probably contributed to aneuploidy formation. Indeed, the aneuploidy indice of HCT116 p53 À/À cells were significantly higher than those of HCT116 p53 þ/þ cells through cell passages ( Figure 5B and C). Moreover, expression of CA-Met significantly increased aneuploidy in p53 À/À HCT116 cells ( Figure 5C ). CA-Met expression in HCT116 p53 À/À cells resulted in almost 3-fold higher aneuploidy index than that in vector control cells at 1 month ( Figure 5C, middle panel) . The increased aneuploidy index in HCT116 p53 À/À cells also remained high after 2 months. Increase in the aneuploidy index was even observed at 0 month (29.1% for CA-Met versus 17.0% for control) because several rounds of cell proliferation had already occurred during the selection process. However, the average numbers of chromosomes were not significantly different among any of the cells tested (data not shown), suggesting that these cells might undergo relatively equivalent gain and loss of chromosomes. Together, our data indicate that the increase of aneuploidy by CA-Met is related with the p53 status of the cell.
Given that the Akt activation is important for centrosome amplification and multinucleated cell formation in CA-Met cells, inhibition of Akt activation may reduce aneuploidy formation. To address that, Fig. 4 . Reduction of the cells with multicentrosomes and multinuclei by suppression of PI3K pathway. (A and C) Vector and CA-Met transfectants were additionally transfected with one of the Akt-specific siRNAs (Akt1 and Akt2) or control scrambled siRNA using oligofectamine reagent (A) or with dominant-negative form of Akt (DN-Akt) or PTEN using polyethylenimine reagent (C) and cultured for 48 h before nocodazole treatment. After 12 h, cells released from nocodazole treatment were analyzed for multicentrosomes by staining with anti-c-tubulin antibody. Cell number 5 300, mean ± SD from three independent experiments. Ã P , 0.05, ÃÃ P , 0.005, by Student's t-test. (B and D) Vector and CA-Met transfectants were transfected with either siRNAs (B) or indicated plasmids (D) in the same manner with (A) or (C), respectively. After 48 h, multinucleated cells were analyzed by 4#,6-diamidino-2-phenylindole staining for nuclei and immunostaining for a-tubulin. Cell number 5 300, mean ± SD from three independent experiments. Ã P,0.05, ÃÃ P , 0.005, by Student's t-test. (E) Cell lysates from the samples harvested as described above were subjected to western blot analysis using anti-phospho-Akt antibody. Actin was used as a loading control. (F) Vector and CA-Met transfectants were additionally transfected with PTEN expression vector and cell cycle profiles were determined by flow cytometry at 2 days after transfection.
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we transfected M1268T complementary DNA along with PTEN into HCT116 cells lacking p53 gene (HCT116 p53 À/À cells) and survival clones were selected in the presence of G418 (500 lg/ml). Western blotting showed that CA-Met and PTEN proteins were properly expressed in these cells ( Figure 6A) . Notably, the aneuploidy index in HCT116 p53 À/À cells was relatively high (Figure 6B ), which is almost twice of HeLa cells ( Figure 2C ), suggesting that loss of p53 contributed to increased aneuploidy in these cells. Expression of CA-Met increased the aneuploidy index from 15 to 26%, whereas co-expression of PTEN partly suppressed the CA-Met-induced aneuploidy formation ( Figure 6B ). Collectively, these data suggest that CA-Metinduced CIN is at least partly mediated by the PI3K-Akt pathway. 
Met-mediated CIN via Akt activation Discussion
Oncogenesis is a complicated process that mediates many different cellular and physiological events. Met is overexpressed and mutated in a variety of human malignancies (15) and its pleiotropic actions on angiogenesis (41), invasion, cellular motility (5), cell growth (3, 4) and cell death (42) appear to be deeply related with its oncogenic property. Here, we demonstrated an additional function of oncogenic Met promoting centrosome amplification and CIN. Recently, centrosomes have attracted much attention due to their critical roles in the proper segregation of chromosomes. Faulty centrosomes have been strongly implicated as a primary cause of CIN and aneuploidy in cancer development (22, 24, 25) . Interestingly, in hereditary papillary renal carcinoma chromosome harboring germ line mutation of Met was found to be selectively amplified (43) . Although the mechanism involved in selective amplification of chromosome harboring Met mutant allele has not been suggested, amplification of the activating Met mutation was found to play key roles in promoting tumorigenesis in vivo (44) . Furthermore, 4 of 10 tumor explants induced by injection of tetraploid p53 À/À mammary epithelial cells showed amplification of chromosome region harboring Met (16) , suggesting the importance of aberrant activation of Met induced by CIN. Taken together with our results showing the induction of CIN by activating mutant of Met, we assume that CIN and activation of Met might act as a positive feedback in the process of carcinogenesis.
RTKs are key initiators of signaling cascades and therefore, mutations on them have multiple effects on various cellular proteins. Oncogenic RTKs often utilize the Ras-Raf-MAPK pathway to stimulate cellular proliferation (45) . The P13K cascade is another important contributor in tumorigenesis. P13K can initiate changes in gene transcription, cell motility and anti-apoptotic signaling (46, 47) . In the present study, we showed that the PI3K-Akt pathway also mediates centrosome amplification. Knock down of Akt expression by siRNA or overexpression of the DN-Akt resulted in a clear abrogation of centrosome amplification in CA-Met cells ( Figure 4) . As far as we know, this is the first observation illustrating Akt activity in deregulated centrosome biogenesis. Intriguingly, Akt as well as other proteins in the PI3K-mTOR signaling pathway can localize to the centrosome (48) (49) (50) . TSC1, a known substrate protein of Akt, localizes to the centrosome and plays a role in centrosome duplication via the mTOR pathway (50) . It has also been shown that glycogen synthase kinase 3, one of the target molecules of Akt, is present along the length of spindle microtubules and that a fraction of glycogen synthase kinase 3 is phosphorylated during mitosis particularly at the spindle poles with concomitant appearance of phosphorylated Akt at the centrosome (48) . We investigated the possibility of centrosome localization of phosphorylated Akt and glycogen synthase kinase 3, but failed (data not shown). Although our preliminary test revealed supernumerary centrosome formation by overexpression of wild-type Akt (H.-J.Nam unpublished results), the underlying mechanisms involved in Akt-mediated centrosome amplification should be resolved in the future study.
Centrosome biogenesis and maintenance of genomic integrity have been closely correlated with p53 status. We observed that the CA-Met induced centrosome amplification in HeLa cells ( Figure 1C ), which have low or no p53 activity, and the ability of CA-Met to induce aneuploidy was influenced by p53 status ( Figure 5 ). p53 is shown to participate in the regulation of centrosome duplication by direct binding to centrosome, independent of its transactivation function (51) . In addition, centrosome reduplication can be triggered by high Cdk2/cyclin E activity in the absence of p53 (38, 52) , which was not the case in our system (supplementary Figure 3 is available at Carcinogenesis Online). It is also possible that the hyperactive Met-PI3K-Akt axis accelerates centrosome duplication cycle and p53 behaves as a safeguard to suppress formation of supernumerary centrosomes. It is noteworthy that frequency of cells with multicentrosome showed almost no difference between CA-Met cells and vector control cells in p53 À/À background. It is possible that basal machineries yet uncharacterized leading to supernumerary centrosome are more active in HCT116 cells than in HeLa cells. Without p53, these unknown machineries may not be checked, leading high frequency of cells with multicentrosome ($25%) as shown in Figure 5A . Therefore, it is probably that it would be hard to see additional effect of CA-Met on supernumerary centrosomes in HCT116 p53 À/À cells. The ability of CA-Met inducing higher aneuploidy index than vector control cells in spite of almost the same level of supernumerary centrosome in HCT116 p53 À/À cells also suggest the possibility that CA-Met induces CIN through unidentified mechanisms along with supernumerary centrosome formation in these cells. Thus, the principal mechanism for CIN induction by CA-Met might be cell line context-dependent. Anyhow, the oncogenic property of CA-Met mediated through centrosome amplification and aneuploidy largely depends on p53 status. This may not be greatly surprising because cellular p53 induces apoptosis, cell cycle arrest and senescence when cells encounter oncogenic stresses (53) . Recently, Kim et al. (54) also reported that activation of PI3K signaling by mutations in PTEN or overexpression of PIK3CA, a constitutively active form of PI3K, could lead to activation of p53-mediated senescence-like growth arrest in human À/À cells were transfected with CA-Met along with PTEN followed by selection in the presence of G418 (500 lg/ml). Expression of Met and PTEN were determined by western blotting. (B) Metaphase spread of indicated cells was prepared by treatment with nocodazole for 12 h, and Giemsa staining was performed to count the chromosome numbers in 100 cells. The numbers of cells with the designated chromosome number on the x-axis are presented. Aneuploidy indices were calculated as described in the Materials and Methods.
H.-J. Nam et al. cells. Therefore, it is probable that the critical role of p53 in prevention of CIN in our system is due to its dual role, namely prevention of centrosome amplification and removal of cells with CIN.
In summary, our data show that HGF/Met signaling induces centrosome amplification and CIN via the PI3K-Akt pathway. Thus, it seems that oncogenic growth factor/growth factor receptor not only control cell cycle progression but also clearly have cross talk to regulate mitosis and that the widespread appearance of CIN in human cancers might be due to the widespread abnormalities in growth factor signaling in human cancers. Supplementary Figures 1-3 
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